Immunogene therapy against colon cancer metastasis using an adenovirus vector expressing CD40 ligand

Surgery

Volumn 148, Issue 5, 2010, Pages 925-935

  Iida, Tomonori ^a   Shiba, Hiroaki ^a   Misawa, Takeyuki ^a   Ohashi, Toya ^a   Eto, Yoshikatsu ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CANCER ANTIBODY; CD40 LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELLULAR IMMUNITY; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EX VIVO STUDY; GENE THERAPY; HISTOLOGY; HUMORAL IMMUNITY; IMMUNOGENETICS; IN VITRO STUDY; LIVER CANCER; MALE; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME; ADENOVIRIDAE; ANIMAL; COLONIC NEOPLASMS; FISCHER 344 RAT; GENE VECTOR; GENETICS; IMMUNOLOGY; PATHOLOGY; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; CD40 LIGAND; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE THERAPY; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE; RATS; RATS, INBRED F344; GENETIC THERAPY;

EID: 77958109234     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.02.004     Document Type: Article

References (46)

1. J. Ferlay, E. Bray, P. Pisani, and D.M. Parkin GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase number 5, version 2.0 2004 IARC Press Lyon, France
2. T. Livraghi Guidelines for treatment of liver cancer Eur J Ultrasound 13 2001 167 176
3. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, and A.M. Bouvier Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 2006 254 259
4. L. Vénat-Bouvet, F. Saint-Marcoux, C. Lagarde, P. Peyronnet, V. Lebrun-Ly, and N. Tubiana-Mathieu Irinotecan-based chemotherapy in a metastatic colorectal cancer patient under haemodialysis for chronic renal dysfunction: two cases considered Anticancer Drugs 18 2007 977 980
5. J. Xu, Y. Zhong, N. Weixin, Q. Xinyu, L. Yanhan, and R. Li Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery Ann Surg 245 2007 583 590
6. R. Gray, J. Barnwell, C. McConkey, R.K. Hills, N.S. Williams for the Quasar Collaborative Group Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 2007 2020 2029
7. M. Roy, T. Waldschmidt, A. Aruffo, J.A. Ledbetter, and R.J. Noelle The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells J Immunol 151 1993 2497 2510
8. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Ann Rev Immunol 16 1998 111 135
9. S.R. Bennett, F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature 393 1998 478 480
10. S.P. Schoenberger, R.E. Toes, E.I. van der Voort, R. Offringa, and C.J. Melief T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions Nature 393 1998 480 483
11. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Ann Rev Immunol 16 1998 111 135
12. T. Kikuchi, N. Miyazawa, M.A. Moore, and R.G. Crystal Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells Cancer Res 60 2000 6391 6395
13. T. Kikuchi, and R.G. Crystal Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells Hum Gene Ther 10 1999 1375 1387
14. V. Schmitz, M. Barajas, L. Wang, D. Peng, M. Duarte, and J. Prieto Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma Hepatology 34 2001 72 81
15. M. Noguchi, K. Imaizumi, T. Kawabe, H. Wakayama, Y. Horio, and Y. Sekido Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer Cancer Gene Ther 8 2001 421 429
16. H. Dzojic, A. Loskog, T.H. Tötterman, and M. Essand Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model Prostate 66 2006 831 838
17. T. Kimura, T. Ohashi, T. Kikuchi, H. Kiyota, Y. Eto, and Y. Ohishi Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vector Cancer Gene Ther 10 2003 833 839
18. R. Vereecque, G. Buffenoir, C. Preudhomme, D. Hetuin, F. Bauters, and P. Fenaux Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease Gene Ther 7 2000 1312 1316
19. M. Urashima, H. Suzuki, Y. Yuza, M. Akiyama, N. Ohno, and Y. Eto An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium Blood 95 2000 1258 1263
20. S. Chouaib, C. Asselin-Paturel, F. Mami-Chouaib, A. Caignard, and J.Y. Blay The host-tumor immune conflict: from immunosuppression to resistance and destruction Immunol Today 18 1997 493 497
21. K. Hallermalm, A. De Geer, R. Kiessling, V. Levitsky, and J. Levitskaya Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes Cancer Res 64 2004 6775 6782
22. Y. Sun, D. Peng, J. Lecanda, V. Schmitz, M. Barajas, and C. Qian In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity Gene Ther 7 2000 1467 1476
23. Y. Inoue, Y. Kashima, K. Aizawa, and K. Hatakeyama A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response Jpn J Cancer Res 82 1991 90 97
24. E. Song, J. Chen, N. Ouyang, M. Wang, M.S. Exton, and U. Heemann Kupffer cells of cirrhotic rat livers sensitize colon cancer cells to Fas-mediated apoptosis Br J Cancer 84 2001 1265 1271
25. E. Taguchi, K. Nakamura, T. Miura, M. Shibuya, and T. Isoe Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model Cancer Sci 99 2008 623 630
26. Y. Kanegae, G. Lee, Y. Sato, M. Tanaka, T. Sakaki, and S. Sugano Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific cre recombinase Nucleic Acids Res 23 1995 3816
27. H. Niwa, K. Yamamura, and Y. Miyazaki Efficient selection for high expression transfectants with a novel eukaryotic vector Gene 108 1991 193
28. Y. Kanegae, M. Makimura, and I. Saito A simple and efficient method for purification of infectious recombinant adenovirus Jpn J Med Sci Biol 47 1994 157 166
29. T. Kikuchi, Y. Akasaki, S. Homma, T. Abe, M. Kurimoto, and T. Ohno Antitumor activity of interleukin-18 on mouse glioma cells J Immunother 23 2000 184 189
30. P.A. Monach, H. Schreiber, and D.A. Rowley CD4+ and B lymphocytes in transplantation immunity Transplantation 55 1993 1356 1361
31. M. Fujieda, N. Oishi, and T. Kurashige Antibody to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment Clin Exp Immunol 107 1997 120 126
32. S.A. Quezada, L.Z. Jarvinen, E.F. Lind, and R.J. Noelle CD40/CD154 interactions at the interface of tolerance and immunity Ann Rev Immunol 22 2004 307 328
33. A.S. Loskog, M.E. Fransson, and T.T. Totterman AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model Clin Cancer Res 11 2005 8816 8821
34. H. Zhu, Y. Zhu, J. Hu, W. Hu, Y. Liao, and J. Zhang Adenovirus-mediated small hairpin RNA targeting Bcl-XL as therapy for colon cancer Int J Cancer 121 2007 1366 1372
35. D. Hoffmann, W. Bayer, and O. Wildner Local and distant immune-mediated control of colon cancer growth with fusogenic membrane glycoproteins in combination with viral oncolysis Hum Gene Ther 18 2007 435 450
36. K. Okuno, N. Hirai, Y.S. Lee, I. Kawai, H. Shigeoka, and M. Yasutomi Involvement of liver-associated immunity in hepatic metastasis formation J Surg Res 75 1998 148 152
37. G.Y. Kwon, J. Jeong, J.K. Woo, H.Y. Choi, M.J. Lee, and J.K. Ko Co-expression of bfl-1 enhances host response in the herpes simplex virus-thymidine kinase/ganciclovir gene therapy system Biochem Biophys Res Commun 303 2003 756 763
38. T. Kikuchi, M.A. Moore, and R.G. Crystal Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors Blood 96 2000 91 99
39. K. Imaizumi, T. Kawabe, S. Ichiyama, H. Kikutani, H. Yagita, and K. Shimokata Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction Am J Physiol 277 1999 L49 L57
40. A. Loskog, H. Dzojic, S. Vikman, C. Ninalga, M. Essand, and O. Korsgren Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor microenvironment J Immunol 172 2004 7200 7205
41. A. Loskog, T.H. Tötterman, A. Böhle, and S. Brandau In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154 Cancer Gene Ther 9 2002 846 853
42. B. Koppold, G. Sauer, H. Buening, M. Hallek, R. Kreienberg, and H. Deissler Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy J Cancer Res Clin Oncol 132 2006 787 794
43. Y. Liu, X. Zhang, W. Zhang, Z. Chen, T. Chan, and K. Ali Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity Cancer Gene Ther 9 2002 202 208
44. A. Saudemont, G. Buffenoir, A. Denys, P. Desreumaux, N. Jouy, and D. Hetuin Gene transfer of CD154 and IL-12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia Leukemia 16 2002 1637 1644
45. H.W. Chen, Y.P. Lee, Y.F. Chung, Y.C. Shih, J.P. Tsai, and M.H. Tao Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy Int Immunol 15 2003 427 435
46. W.G. Wierda, M.J. Cantwell, S.J. Woods, L.Z. Rassenti, C.E. Prussak, and T.J. Kipps CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood 96 2000 2917 2924